StockDriftsStockDriftsTop 50 Bellevue Group AG Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| AMGN | AMGEN INC | 6.49% | 851.5K | $308.4M | +188.31%(+556.19K) | $348.82(+19.31%) | 2026-06-30 | |
| VRTX | VERTEX PHARMACEUTICALS INC | 6.05% | 578.6K | $287.4M | -15.14%(-103.27K) | $293.05(+72.58%) | 2026-06-30 | |
| ARGX | ARGENX SE | 5.88% | 301.0K | $279.3M | -3.83%(-12.00K) | $150.94(+550.87%) | 2026-06-30 | |
| GILD | GILEAD SCIENCES INC | 5.74% | 2.16M | $272.7M | +84.53%(+988.89K) | $129.85(+6.55%) | 2026-06-30 | |
| RVMD | REVOLUTION MEDICINES INC | 4.13% | 1.05M | $196.3M | -32.14%(-496.44K) | $32.67(+557.06%) | 2026-06-30 | |
| ORKA | ORUKA THERAPEUTICS INC | 3.32% | 1.66M | $157.7M | +226.86%(+1.15M) | $60.96(+84.52%) | 2026-06-30 | |
| INSM | INSMED INC | 3.13% | 1.39M | $148.6M | +13786.96%(+1.38M) | $129.23(-4.25%) | 2026-06-30 | |
| SRRK | SCHOLAR ROCK HLDG CORP | 2.83% | 2.45M | $134.7M | -31.66%(-1.14M) | $25.28(+107.74%) | 2026-06-30 | |
| NUVL | NUVALENT INC | 2.74% | 1.05M | $130.1M | +0.00%(+0) | $93.65(+32.36%) | 2026-06-30 | |
| VRDN | VIRIDIAN THERAPEUTICS INC | 2.6% | 6.73M | $123.7M | +0.09%(+5.76K) | $25.99(-15.04%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | +15.12% | +52.57% | +8.95% | +53.53% |
| Top 20 Holdings Unweighted | +9.65% | +31.84% | +5.21% | +28.89% |
Bellevue Group AG reports $4.75B in US-listed equity holdings across 148 positions in its most recent 13F filing. Its largest disclosed positions are AMGN (6.5%), VRTX (6.0%) and ARGX (5.9%). The top 20 holdings account for 63.47% of reported assets. Its disclosed equity book has returned +52.57% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Bellevue Group AG, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Bellevue Group AG’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1674546). View Bellevue Group AG’s 13F filings on SEC